Parecoxib sodium is a selective cyclooxygenase-2 (COX-2) inhibitor primarily used as an injectable prodrug for the management of acute pain in patients unable to take oral medications. This non-steroidal… Read more








![Chemical structure of N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F198471-06-6-N-4-5-Methyl-3-phenyl-4-isoxazolylphenylsulfonylacetamide.png&w=3840&q=75)




Parecoxib sodium is a selective cyclooxygenase-2 (COX-2) inhibitor primarily used as an injectable prodrug for the management of acute pain in patients unable to take oral medications. This non-steroidal anti-inflammatory drug is converted into its active metabolite, valdecoxib, within the body. Laboratories rely on high-quality reference standards of parecoxib sodium, including its pharmacopeial and non-pharmacopeial impurities, to perform rigorous impurity profiling and ensure drug product consistency. These materials, alongside stable isotope labelled compounds, are critical for method validation and accurate quantitative analysis during quality control processes. By utilizing these specialized analytical standards, researchers and pharmaceutical scientists can effectively monitor degradation products and maintain compliance with regulatory standards throughout the development and manufacturing lifecycle of this medication.